Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives. (Q38234170)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25064061 AND SRC:MED&resulttype=core&format=json

10 March 2020

title

Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25064061 AND SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25064061 AND SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Jesse V Veenvliet

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25064061 AND SRC:MED&resulttype=core&format=json

10 March 2020

publication date

27 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25064061 AND SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25064061 AND SRC:MED&resulttype=core&format=json

10 March 2020

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25064061 AND SRC:MED&resulttype=core&format=json

10 March 2020

issue

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25064061 AND SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

4703-4727

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25064061 AND SRC:MED&resulttype=core&format=json

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

How to make a mesodiencephalic dopaminergic neuron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Developmental origin and fate of meso-diencephalic dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

En1 and Wnt signaling in midbrain dopaminergic neuronal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Getting connected in the dopamine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Specification of dopaminergic and serotonergic neurons in the vertebrate CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

The midbrain--hindbrain boundary organizer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Otx genes in brain morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Otx genes and the genetic control of brain morphogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Induction and specification of midbrain dopaminergic cells: focus on SHH, FGF8, and TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

BMP and TGF-β pathway mediators are critical upstream regulators of Wnt signaling during midbrain dopamine differentiation in human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Engrailed-1 as a target of the Wnt-1 signalling pathway in vertebrate midbrain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Lmx1b is essential for Fgf8 and Wnt1 expression in the isthmic organizer during tectum and cerebellum development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Wnt1-regulated genetic networks in midbrain dopaminergic neuron development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

An Lmx1b-miR135a2 regulatory circuit modulates Wnt1/Wnt signaling and determines the size of the midbrain dopaminergic progenitor pool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Retinoic acid induces stage-specific repatterning of the rostral central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Mammalian achaete-scute and atonal homologs regulate neuronal versus glial fate determination in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurr1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Forebrain gene expression domains and the evolving prosomeric model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

The embryonic vertebrate forebrain: the prosomeric model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

A developmental ontology for the mammalian brain based on the prosomeric model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Molecular marker differences relate to developmental position and subsets of mesodiencephalic dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

A homeodomain gene Ptx 3 has highly restricted brain expression in mesencephalic dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

A double-deletion mutation in the Pitx3 gene causes arrested lens development in aphakia mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Deletion in the promoter region and altered expression of Pitx3 homeobox gene in aphakia mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Pitx3 is required for development of substantia nigra dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Pitx3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Retinoic acid-dependent and -independent gene-regulatory pathways of Pitx3 in meso-diencephalic dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Pitx3 is a critical mediator of GDNF-induced BDNF expression in nigrostriatal dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

A MicroRNA feedback circuit in midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

MyomiR-133 regulates brown fat differentiation through Prdm16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

miR-133a regulates adipocyte browning in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Direct regulation of Pitx3 expression by Nurr1 in culture and in developing mouse midbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Identification of Dlk1, Ptpru and Klhl1 as novel Nurr1 target genes in meso-diencephalic dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Expression patterns of the homeo box-containing genes En-1 and En-2 and the proto-oncogene int-1 diverge during mouse development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Midbrain dopaminergic neurons: control of their cell fate by the engrailed transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Cell-autonomous FGF signaling regulates anteroposterior patterning and neuronal differentiation in the mesodiencephalic dopaminergic progenitor domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Specification of dopaminergic subsets involves interplay of En1 and Pitx3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Cholecystokinin-induced inhibition of dopamine neurotransmission: comparison with chronic haloperidol treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Modulatory role for CCK-B antagonists in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Otx genes in neurogenesis of mesencephalic dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Otx2 selectively controls the neurogenesis of specific neuronal subtypes of the ventral tegmental area and compensates En1-dependent neuronal loss and MPTP vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Otx2 controls neuron subtype identity in ventral tegmental area and antagonizes vulnerability to MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Otx2 expression is restricted to dopaminergic neurons of the ventral tegmental area in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

The transcription factor orthodenticle homeobox 2 influences axonal projections and vulnerability of midbrain dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Increased dopaminergic innervation in the brain of conditional mutant mice overexpressing Otx2: effects on locomotor behavior and seizure susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson's disease: implications for treating Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Identification of intrinsic determinants of midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Lmx1a and Lmx1b Function Cooperatively to Regulate Proliferation, Specification, and Differentiation of Midbrain Dopaminergic Progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Lmx1a encodes a rostral set of mesodiencephalic dopaminergic neurons marked by the Wnt/B-catenin signaling activator R-spondin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Specific and integrated roles of Lmx1a, Lmx1b and Phox2a in ventral midbrain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Dopamine neuron agenesis in Nurr1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Epigenetic mechanisms in the development and maintenance of dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Foxa1 and Foxa2 function both upstream of and cooperatively with Lmx1a and Lmx1b in a feedforward loop promoting mesodiencephalic dopaminergic neuron development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Signalling mechanisms underlying development and maintenance of dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Wnt/β-catenin signaling in midbrain dopaminergic neuron specification and neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Estrogen and the development and protection of nigrostriatal dopaminergic neurons: concerted action of a multitude of signals, protective molecules, and growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Repairing the parkinsonian brain with neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Overexpression of pitx3 upregulates expression of BDNF and GDNF in SH-SY5Y cells and primary ventral mesencephalic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Death receptors and caspases but not mitochondria are activated in the GDNF- or BDNF-deprived dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Absolute requirement of GDNF for adult catecholaminergic neuron survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

A null mutation in TGF-alpha leads to a reduction in midbrain dopaminergic neurons in the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Expressing TrkC from the TrkA locus causes a subset of dorsal root ganglia neurons to switch fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Low-threshold mechanoreceptor subtypes selectively express MafA and are specified by Ret signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

FGF signalling pathways in development of the midbrain and anterior hindbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Fibroblast growth factor 2 regulates dopaminergic neuron development in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Fibroblast growth factor 2 regulates adequate nigrostriatal pathway formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Fgfr2 and Fgfr3 are not required for patterning and maintenance of the midbrain and anterior hindbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

FGFR1 is independently required in both developing mid- and hindbrain for sustained response to isthmic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

FGF regulated gene-expression and neuronal differentiation in the developing midbrain-hindbrain region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Fibroblast growth factor receptors cooperate to regulate neural progenitor properties in the developing midbrain and hindbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Roles of FGF20 in dopaminergic neurons and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

A specific survival response in dopamine neurons at most risk in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Docosahexaenoic Acid Promotes Dopaminergic Differentiation in Induced Pluripotent Stem Cells and Inhibits Teratoma Formation in Rats with Parkinson-Like Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Regulation of tyrosine hydroxylase gene expression by retinoic acid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Dynamics and precision in retinoic acid morphogen gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Noise drives sharpening of gene expression boundaries in the zebrafish hindbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Retinoic acid regulates the expression of PBX1, PBX2, and PBX3 in P19 cells both transcriptionally and post-translationally

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Hox and Pbx factors control retinoic acid synthesis during hindbrain segmentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Dhrs3 protein attenuates retinoic acid signaling and is required for early embryonic patterning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Complex regulation of cyp26a1 creates a robust retinoic acid gradient in the zebrafish embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Midbrain dopaminergic neurons utilize nitric oxide/cyclic GMP signaling to recruit ERK that links retinoic acid receptor stimulation to up-regulation of BDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Runx2 deficiency in chondrocytes causes adipogenic changes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Transcriptional repression of pref-1 by glucocorticoids promotes 3T3-L1 adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Midbrain expression of Delta-like 1 homologue is regulated by GDNF and is associated with dopaminergic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Neurons in the monoaminergic nuclei of the rat and human central nervous system express FA1/dlk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Delta-like 1 participates in the specification of ventral midbrain progenitor derived dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Effect of retinoic acid and delta-like 1 homologue (DLK1) on differentiation in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Dlk1 promotes a fast motor neuron biophysical signature required for peak force execution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Dlk1 influences differentiation and function of B lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Multiple Notch signaling events control Drosophila CNS midline neurogenesis, gliogenesis and neuronal identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Asymmetric cell division and Notch signaling specify dopaminergic neurons in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Association of transcription factor polymorphisms PITX3 and EN1 with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

PITX3 polymorphism is associated with early onset Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

The transcription factor PITX3 is associated with sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Do polymorphisms in transcription factors LMX1A and LMX1B influence the risk for Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Investigation of TGFB2 as a candidate gene in multiple sclerosis and Parkinson’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Redox regulation by Pitx2 and Pitx3 is critical for fetal myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Homeoprotein signaling in development, health, and disease: a shaking of dogmas offers challenges and promises from bench to bed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

'Rejuvenation' protects neurons in mouse models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltage-dependent sodium conductances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Calcium homeostasis, selective vulnerability and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Towards stem cell replacement therapies for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Rewiring the brain with cell transplantation in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Progress in Parkinson's disease-where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Direct generation of functional dopaminergic neurons from mouse and human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Expression of early developmental markers predicts the efficiency of embryonic stem cell differentiation into midbrain dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Epigenetic memory in induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Directed midbrain and spinal cord neurogenesis from pluripotent stem cells to model development and disease in a dish

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Dissecting the diversity of midbrain dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Individual dopamine midbrain neurons: functional diversity and flexibility in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Molecular basis for catecholaminergic neuron diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP binds to neuromelanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Evidence for neuromelanin involvement in MPTP-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

The neuron identity problem: form meets function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

A unique population of ventral tegmental area neurons inhibits the lateral habenula to promote reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-014-1681-5

Factors in the genetic background suppress the engrailed-1 cerebellar phenotype.

21 January 2018

1 reference

12 December 2020

Pref-1 in brown adipose tissue: specific involvement in brown adipocyte differentiation and regulatory role of C/EBPδ.

1 reference

12 December 2020

Pref-1, a gatekeeper of adipogenesis

1 reference

12 December 2020

Human ES and iPS cells as cell sources for the treatment of Parkinson's disease: current state and problems

1 reference

12 December 2020

Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.

1 reference

12 December 2020

The transcription factor Lmx1b maintains Wnt1 expression within the isthmic organizer.

1 reference

12 December 2020

Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease

1 reference

12 December 2020

Specification of the anterior hindbrain and establishment of a normal mid/hindbrain organizer is dependent on Gbx2 gene function

1 reference

12 December 2020

Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy

1 reference

12 December 2020

Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium.

1 reference

12 December 2020

Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo.

1 reference

12 December 2020

Multiple developmental defects in Engrailed-1 mutant mice: an early mid-hindbrain deletion and patterning defects in forelimbs and sternum

1 reference

12 December 2020

Retinoic acid modifies development of the midbrain-hindbrain border and affects cranial ganglion formation in zebrafish embryos

1 reference

12 December 2020

Characterization of the inhibitory effect of growth hormone on primary preadipocyte differentiation

1 reference

12 December 2020

Genome wide profiling of dopaminergic neurons derived from human embryonic and induced pluripotent stem cells

1 reference

12 December 2020

Lmx1b can promote the differentiation of embryonic stem cells to dopaminergic neurons associated with Parkinson's disease

1 reference

12 December 2020

Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson’s disease

1 reference

12 December 2020

Possible roles of DLK1 in the Notch pathway during development and disease

1 reference

12 December 2020

Foxa1 and Foxa2 transcription factors regulate differentiation of midbrain dopaminergic neurons

1 reference

12 December 2020

Differentiation of human epidermal neural crest stem cells (hEPI-NCSC) into virtually homogenous populations of dopaminergic neurons

1 reference

12 December 2020

Fate of midbrain dopaminergic neurons controlled by the engrailed genes

1 reference

12 December 2020

Genome wide expression profiling of the mesodiencephalic region identifies novel factors involved in early and late dopaminergic development

1 reference

12 December 2020

Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease

1 reference

12 December 2020

Isthmus organizer for midbrain and hindbrain development

1 reference

12 December 2020

Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into parkinsonian mice.

1 reference

12 December 2020